We recently published 10 Most Undervalued Pharma Stocks To Buy Now. AstraZeneca PLC stands fifth on our list among the most undervalued stocks. AstraZeneca PLC (NASDAQ:AZN), a global biopharmaceutical ...

AstraZeneca AZN -1.94% has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash ...

AstraZeneca R&D is contributing SEK 100 million and the University of Gothenburg and Region Västra Götaland are each contributing with SEK 25 million. Deeper understanding that meets needs ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the United States by 2030, it said on Monday, the latest big investment by a pharmaceutical company ...

AstraZeneca on Tuesday said it would invest $50billion (£37.1billion) in the US by 2030, creating 'tens of thousands' of highly skilled 'direct and indirect' jobs, while 'powering growth and ...

AstraZeneca ’s AZN 3.11% longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to ...

Jenny Nyström, University of Gothenburg, Regina Fritsche-Danielson, AstraZeneca, Helén Eliasson, Region Västra Götaland, and Sara Mazur, Knut and Alice Wallenberg Foundation Metabolism and ...

AstraZeneca has agreed to acquire U.S.-based vaccine developer Icosavax for $1.1 billion, the companies announced Tuesday, to gain access to experimental vaccines targeting common respiratory ...

Tangent AstraZeneca reported $33.7 billion in total revenue through the third quarter and raised its guidance for total revenue this year from a low-to-mid single-digit percentage increase to a ...